UCB Pharma (Germany)

About

In recent decades, authors affiliated with UCB Pharma (Germany) have published 626 papers, which have received a total of 18.2k indexed citations. Scholars at this organization have produced 139 papers in Rheumatology, 134 papers in Psychiatry and Mental health and 129 papers in Neurology on the topics of Epilepsy research and treatment (109 papers), Pharmacological Effects and Toxicity Studies (109 papers) and Spondyloarthritis Studies and Treatments (100 papers). Their work is cited by papers focused on Neurology (3.9k citations), Molecular Biology (3.5k citations) and Psychiatry and Mental health (3.2k citations). Authors at UCB Pharma (Germany) collaborate with scholars in Germany, United States and Belgium and have published in prestigious journals including Nature, The Lancet and Nature Communications. Some of UCB Pharma (Germany)'s most productive authors include Thomas Kissel, Youxin Li, Martin Feelisch, Dagmar Fischer, Josef Krieglstein, Barbara Ahlemeyer, Willi Cawello, Babak Boroojerdi, Hans‐Peter Elsässer and Bengt Hoepken.

In The Last Decade

UCB Pharma (Germany)

576 papers receiving 18.1k citations

Countries citing scholars working at UCB Pharma (Germany)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (Germany). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (Germany) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (Germany) more than expected).

Fields of papers published by authors at UCB Pharma (Germany)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with UCB Pharma (Germany) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with UCB Pharma (Germany) at the time of their publication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026